Unknown

Dataset Information

0

High throughput discovery of influenza virus neutralizing antibodies from phage-displayed synthetic antibody libraries.


ABSTRACT: Pandemic and epidemic outbreaks of influenza A virus (IAV) infection pose severe challenges to human society. Passive immunotherapy with recombinant neutralizing antibodies can potentially mitigate the threats of IAV infection. With a high throughput neutralizing antibody discovery platform, we produced artificial anti-hemagglutinin (HA) IAV-neutralizing IgGs from phage-displayed synthetic scFv libraries without necessitating prior memory of antibody-antigen interactions or relying on affinity maturation essential for in vivo immune systems to generate highly specific neutralizing antibodies. At least two thirds of the epitope groups of the artificial anti-HA antibodies resemble those of natural protective anti-HA antibodies, providing alternatives to neutralizing antibodies from natural antibody repertoires. With continuing advancement in designing and constructing synthetic scFv libraries, this technological platform is useful in mitigating not only the threats of IAV pandemics but also those from other newly emerging viral infections.

SUBMITTER: Chen IC 

PROVIDER: S-EPMC5663709 | biostudies-literature | 2017 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

High throughput discovery of influenza virus neutralizing antibodies from phage-displayed synthetic antibody libraries.

Chen Ing-Chien IC   Chiu Yi-Kai YK   Yu Chung-Ming CM   Lee Cheng-Chung CC   Tung Chao-Ping CP   Tsou Yueh-Liang YL   Huang Yi-Jen YJ   Lin Chia-Lung CL   Chen Hong-Sen HS   Wang Andrew H-J AH   Yang An-Suei AS  

Scientific reports 20171031 1


Pandemic and epidemic outbreaks of influenza A virus (IAV) infection pose severe challenges to human society. Passive immunotherapy with recombinant neutralizing antibodies can potentially mitigate the threats of IAV infection. With a high throughput neutralizing antibody discovery platform, we produced artificial anti-hemagglutinin (HA) IAV-neutralizing IgGs from phage-displayed synthetic scFv libraries without necessitating prior memory of antibody-antigen interactions or relying on affinity m  ...[more]

Similar Datasets

| S-EPMC4601012 | biostudies-literature
| S-EPMC4994030 | biostudies-literature
| S-EPMC8726723 | biostudies-literature
| S-EPMC7414213 | biostudies-literature
| S-EPMC4195448 | biostudies-literature
| S-EPMC3556032 | biostudies-literature
| S-EPMC3257230 | biostudies-literature
| S-EPMC2678933 | biostudies-other
| S-EPMC4524473 | biostudies-literature
| S-EPMC8315086 | biostudies-literature